Innovative Launch at 2024 Jeddah International Motor Show: Presenting BAIC’s BJ30 and BJ60
JEDDAH, Saudi Arabia, Oct. 31, 2024 /PRNewswire/ — BAIC is excited to unveil the latest in its rugged and versatile lineup at the 2024 Jeddah International Motor Show with the introduction of the BJ30 series and the BJ60 series. These new models are tailored for adventurous drivers who seek a
CNOOC Limited Announces Mero3 Project Commences Production
HONG KONG, Oct. 30, 2024 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces that Mero3 Project has commenced production safely. Mero field is located in the Santos Basin pre-salt southeastern offshore Brazil, about
BRICS Summit safeguards the stability of greater BRICS collaboration
BEIJING, Oct. 30, 2024 /PRNewswire/ — A news report by China.org.cn on the 16th BRICS Summit: Recently, the 16th BRICS Summit concluded in Kazan, an ancient city by the Volga in Russia. As the bloc’s first meeting since its expansion of five new members in BRICS, the event drew atten
InvestBev Commits $50 Million to Fuel Growth in the Distillery and Bourbon Barrel Sector
Strategic Funding to Bolster Industry Resilience Amidst Tightened Banking Conditions CHICAGO, Oct. 30, 2024 /PRNewswire/ — InvestBev, a leading private equity firm in the adult beverage sector, has announced a strategic commitment of $50 million through its credit arm to support the distillery
Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescimab Combined with Ligufalimab (CD47) for First-Line Treatment of Head and Neck Squamous Cell Carcinoma (HNSCC), Compared to Pembrolizumab
HONG KONG, Oct. 30, 2024 /PRNewswire/ — Akeso Biopharma (9926.HK) is pleased to announce the enrollment of the first patient in its randomized, controlled, multicenter Phase III clinical study (AK117-302) for head and neck squamous cell carcinoma. This trial evaluates the innovative PD-1/VEGF
MOIN Successfully Complete POC for Cross-Border Tuition Payments, Paving the Way for Solution Commercialization
SEOUL, South Korea, Oct. 30, 2024 /PRNewswire/ — MOIN, a leading cross-border remittance service provider, has successfully collaborated with Visa to address a long-standing challenge in cross-border payments: the inability to seamlessly transmit detailed non-financial data alongside financial
Satsuma Pharmaceuticals and SNBL Resubmits the New Drug Application for STS101 (Dihydroergotamine Nasal Powder) for the Acute Treatment of Migraine With or Without Aura
DURHAM, N.C., Oct. 30, 2024 /PRNewswire/ — Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company, and its corporate parent, Shin Nippon Biomedical Laboratories, Ltd. (TSE:2395), today announced the resubmission of the new drug application (NDA) for the investigational product S
Apes Hill Barbados Champions Sustainability at Luxury Resort Residential Property
ST. JAMES, Barbados, Oct. 30, 2024 /PRNewswire/ — Luxury resorts and real estate communities are stepping up their commitment to sustainability, aiming not only to offer world-class facilities but also to protect the environment and contribute to the well-being of surrounding ecosystems. A key
Dot Inc. and WEBTOON Entertainment Release World’s First Tactile Digital Comics
Hit WEBTOON series “Yumi’s Cells” and “Hooky” will be made available for free in braille on Dot Inc.’s Dot Pad technology, expanding access to more fans around the world Key supporting assets available HERE SEOUL, South Korea, Oct. 30, 2024 /PRNewswire/ — WE
XIAO HUA (EDWARD) GONG, File No. 2022-14
TORONTO, Oct. 30, 2024 /CNW/ – Following a hearing held today, the Tribunal issued an Order in the above-named matter approving the Settlement Agreement reached between the Ontario Securities Commission and Xiao Hua (Edward) Gong. Take notice the hearing dates scheduled for December 12 and 13